Literature DB >> 28341742

pH regulation in early endosomes and interferon-inducible transmembrane proteins control avian retrovirus fusion.

Tanay M Desai1, Mariana Marin1, Caleb Mason1, Gregory B Melikyan2,3.   

Abstract

Enveloped viruses infect host cells by fusing their membranes with those of the host cell, a process mediated by viral glycoproteins upon binding to cognate host receptors or entering into acidic intracellular compartments. Whereas the effect of receptor density on viral infection has been well studied, the role of cell type-specific factors/processes, such as pH regulation, has not been characterized in sufficient detail. Here, we examined the effects of cell-extrinsic factors (buffer environment) and cell-intrinsic factors (interferon-inducible transmembrane proteins, IFITMs), on the pH regulation in early endosomes and on the efficiency of acid-dependent fusion of the avian sarcoma and leukosis virus (ASLV), with endosomes. First, we found that a modest elevation of external pH can raise the pH in early endosomes in a cell type-dependent manner and thereby delay the acid-induced fusion of endocytosed ASLV. Second, we observed a cell type-dependent delay between the low pH-dependent and temperature-dependent steps of viral fusion, consistent with the delayed enlargement of the fusion pore. Third, ectopic expression of IFITMs, known to potently block influenza virus fusion with late compartments, was found to only partially inhibit ASLV fusion with early endosomes. Interestingly, IFITM expression promoted virus uptake and the acidification of endosomal compartments, resulting in an accelerated fusion rate when driven by the glycosylphosphatidylinositol-anchored, but not by the transmembrane isoform of the ASLV receptor. Collectively, these results highlight the role of cell-extrinsic and cell-intrinsic factors in regulating the efficiency and kinetics of virus entry and fusion with target cells.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  endocytosis; fusion protein; pH regulation; viral protein; virus entry

Mesh:

Substances:

Year:  2017        PMID: 28341742      PMCID: PMC5427263          DOI: 10.1074/jbc.M117.783878

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

1.  Evolution of intermediates of influenza virus hemagglutinin-mediated fusion revealed by kinetic measurements of pore formation.

Authors:  R M Markosyan; G B Melikyan; F S Cohen
Journal:  Biophys J       Date:  2001-02       Impact factor: 4.033

2.  Endosome-to-cytosol transport of viral nucleocapsids.

Authors:  Isabelle Le Blanc; Pierre-Philippe Luyet; Véronique Pons; Charles Ferguson; Neil Emans; Anne Petiot; Nathalie Mayran; Nicolas Demaurex; Julien Fauré; Rémy Sadoul; Robert G Parton; J Gruenberg
Journal:  Nat Cell Biol       Date:  2005-06-12       Impact factor: 28.824

3.  Studies of the "chain reversal regions" of the avian sarcoma/leukosis virus (ASLV) and ebolavirus fusion proteins: analogous residues are important, and a His residue unique to EnvA affects the pH dependence of ASLV entry.

Authors:  Sue E Delos; Bonnie La; Allissia Gilmartin; Judith M White
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

4.  Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication.

Authors:  Alexander Karlas; Nikolaus Machuy; Yujin Shin; Klaus-Peter Pleissner; Anita Artarini; Dagmar Heuer; Daniel Becker; Hany Khalil; Lesley A Ogilvie; Simone Hess; André P Mäurer; Elke Müller; Thorsten Wolff; Thomas Rudel; Thomas F Meyer
Journal:  Nature       Date:  2010-01-17       Impact factor: 49.962

5.  Low pH is required for avian sarcoma and leukosis virus Env-dependent viral penetration into the cytosol and not for viral uncoating.

Authors:  Richard J O Barnard; Shakti Narayan; Geethanjali Dornadula; Michael D Miller; John A T Young
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

6.  HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes.

Authors:  Kosuke Miyauchi; Yuri Kim; Olga Latinovic; Vladimir Morozov; Gregory B Melikyan
Journal:  Cell       Date:  2009-05-01       Impact factor: 41.582

7.  IFITM3 inhibits influenza A virus infection by preventing cytosolic entry.

Authors:  Eric M Feeley; Jennifer S Sims; Sinu P John; Christopher R Chin; Thomas Pertel; Li-Mei Chen; Gaurav D Gaiha; Bethany J Ryan; Ruben O Donis; Stephen J Elledge; Abraham L Brass
Journal:  PLoS Pathog       Date:  2011-10-27       Impact factor: 6.823

8.  An early stage of membrane fusion mediated by the low pH conformation of influenza hemagglutinin depends upon membrane lipids.

Authors:  L V Chernomordik; E Leikina; V Frolov; P Bronk; J Zimmerberg
Journal:  J Cell Biol       Date:  1997-01-13       Impact factor: 10.539

9.  Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion.

Authors:  G B Melikyan; R M Markosyan; H Hemmati; M K Delmedico; D M Lambert; F S Cohen
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

10.  Kinetics of endosome acidification detected by mutant and wild-type Semliki Forest virus.

Authors:  M C Kielian; M Marsh; A Helenius
Journal:  EMBO J       Date:  1986-12-01       Impact factor: 11.598

View more
  12 in total

1.  Functional Mapping of Regions Involved in the Negative Imprinting of Virion Particle Infectivity and in Target Cell Protection by Interferon-Induced Transmembrane Protein 3 against HIV-1.

Authors:  Mathilde Delpeuch; Li Zhong; Romain Appourchaux; Julien Burlaud-Gaillard; Kevin Tartour; George Savidis; Abraham Brass; Lucie Etienne; Philippe Roingeard; Andrea Cimarelli
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

2.  HA-Dependent Tropism of H5N1 and H7N9 Influenza Viruses to Human Endothelial Cells Is Determined by Reduced Stability of the HA, Which Allows the Virus To Cope with Inefficient Endosomal Acidification and Constitutively Expressed IFITM3.

Authors:  Luca Hensen; Tatyana Matrosovich; Katrin Roth; Hans-Dieter Klenk; Mikhail Matrosovich
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

3.  Identification of Residues Controlling Restriction versus Enhancing Activities of IFITM Proteins on Entry of Human Coronaviruses.

Authors:  Xuesen Zhao; Mohit Sehgal; Zhifei Hou; Junjun Cheng; Sainan Shu; Shuo Wu; Fang Guo; Sylvain J Le Marchand; Hanxin Lin; Jinhong Chang; Ju-Tao Guo
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

Review 4.  Medicinal Plants and Isolated Molecules Demonstrating Immunomodulation Activity as Potential Alternative Therapies for Viral Diseases Including COVID-19.

Authors:  Hassan A Alhazmi; Asim Najmi; Sadique A Javed; Shahnaz Sultana; Mohammed Al Bratty; Hafiz A Makeen; Abdulkarim M Meraya; Waquar Ahsan; Syam Mohan; Manal M E Taha; Asaad Khalid
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

5.  Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs.

Authors:  Kevin Tartour; Xuan-Nhi Nguyen; Romain Appourchaux; Sonia Assil; Véronique Barateau; Louis-Marie Bloyet; Julien Burlaud Gaillard; Marie-Pierre Confort; Beatriz Escudero-Perez; Henri Gruffat; Saw See Hong; Marie Moroso; Olivier Reynard; Stéphanie Reynard; Elodie Decembre; Najate Ftaich; Axel Rossi; Nannan Wu; Frédérick Arnaud; Sylvain Baize; Marlène Dreux; Denis Gerlier; Glaucia Paranhos-Baccala; Viktor Volchkov; Philippe Roingeard; Andrea Cimarelli
Journal:  PLoS Pathog       Date:  2017-09-28       Impact factor: 6.823

6.  Filoviruses Use the HOPS Complex and UVRAG To Traffic to Niemann-Pick C1 Compartments during Viral Entry.

Authors:  Yuxia Bo; Shirley Qiu; Rory P Mulloy; Marceline Côté
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

7.  Potential Therapies for Infectious Diseases Based on Targeting Immune Evasion Mechanisms That Pathogens Have in Common With Cancer Cells.

Authors:  Jodi Wong; Stephen Yiu Chuen Choi; Rongrong Liu; Eddie Xu; James Killam; Peter W Gout; Yuzhuo Wang
Journal:  Front Cell Infect Microbiol       Date:  2019-02-12       Impact factor: 5.293

Review 8.  Virus Entry: Looking Back and Moving Forward.

Authors:  Ari Helenius
Journal:  J Mol Biol       Date:  2018-04-28       Impact factor: 5.469

9.  Interferon-induced transmembrane protein 3 blocks fusion of sensitive but not resistant viruses by partitioning into virus-carrying endosomes.

Authors:  Krishna C Suddala; Christine C Lee; Paul Meraner; Mariana Marin; Ruben M Markosyan; Tanay M Desai; Fredric S Cohen; Abraham L Brass; Gregory B Melikyan
Journal:  PLoS Pathog       Date:  2019-01-14       Impact factor: 6.823

10.  IFITM3 directly engages and shuttles incoming virus particles to lysosomes.

Authors:  Jennifer S Spence; Ruina He; Hans-Heinrich Hoffmann; Tandrila Das; Emmanuelle Thinon; Charles M Rice; Tao Peng; Kartik Chandran; Howard C Hang
Journal:  Nat Chem Biol       Date:  2019-01-14       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.